• 3159 Citations
  • 32 h-Index
1987 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Pace is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Brain Neoplasms Medicine & Life Sciences
Consensus Medicine & Life Sciences
Pain Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Glioma Medicine & Life Sciences
Psychology Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Epilepsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

  • 3159 Citations
  • 32 h-Index
  • 159 Article
  • 13 Review article
  • 4 Chapter
  • 2 Editorial

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

the Italian Association of Neuro-Oncology, Silvani, A., De Simone, I., Fregoni, V., Biagioli, E., Marchioni, E., Caroli, M., Salmaggi, A., Pace, A., Torri, V., Gaviani, P., Quaquarini, E., Simonetti, G., Rulli, E. & D’Incalci, M., Jan 1 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-462

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Italian Association of Neuro-Oncology, May 6 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-62 8 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence
4 Citations (Scopus)

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

the CI-PeriNomS Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 111-119 9 p.

Research output: Contribution to journalArticle

Physicians
Drug Therapy
Neurologic Examination
Vibration
Outcome Assessment (Health Care)

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Lomustine
Glioblastoma
Survival
temozolomide
Italy

Stroke-like events after brain radiotherapy: a large series with long-term follow-up

Di Stefano, A. L., Berzero, G., Ducray, F., Eoli, M., Pichiecchio, A., Farina, L. M., Cuccarini, V., Brunelli, M. C., Diamanti, L., Condette Auliac, S., Salmaggi, A., Silvani, A., Giometto, B., Pace, A., Vidiri, A., Bourdain, F., Bastianello, S., Ceroni, M. & Marchioni, E., Apr 2019, In : European Journal of Neurology. 26, 4, p. 639-650 12 p.

Research output: Contribution to journalArticle

Radiotherapy
Stroke
Brain
Radiation Injuries
Radiation Effects